Infectious diseases are complex, dynamic, and constantly evolving. Examples during the past 15 years range from changes in transmission patterns of human monkeypox and dengue; more frequent re-emergence of cholera, legionnaire's disease, *E. coli* 0157, hepatitis C and, the haemorrhagic fevers - Marburg, Lassa and Ebola; and emergence of bovine spongiform encephalopathy (BSE), severe acute respiratory syndrome (SARS) and H5N1 influenza.

Causes of emergence and re-emergence include weakened public health infrastructure, increases in human and domestic animal populations, rapid urbanization, and effects on the environment from global warming to deforestation and flooding. Human behavior also plays a major role, ranging from unsafe sexual practices to over- or under-prescribing of antimicrobial drugs, patient adherence, unregulated sale, and indiscriminate use in humans, plants and animals.

Emerging and re-emerging infections occur in a world where international travel and trade facilitate their spread, and where their impact affects economies as well as health. Attempts at regulation to prevent their international spread occurred first in the 14th century quarantines in Venice. They continued during the 19th and 20th centuries in Europe and the Americas through a series of conferences and conventions leading to the International Health Regulations. The goal of the Regulations is to strengthen national capacities to detect and respond to emerging or re-emerging infections when and where they occur, with the guarantee of a safety net of collective detection and response should they cross international borders.

The lesson over the past 15 years - whether from the global response to SARS or preparations for the next influenza pandemic - is that collective action will decrease our vulnerability, and increase our public health security. The challenge is to ensure resources for our collective action under the framework of the International Health Regulations.
